瑞思迈

Resmed Inc. Directors Sell Shares Amid Market Volatility.

ResMed's 15min chart shows MACD Death Cross, KDJ Death Cross signal.

ResMed

ResMed's Dominance in CPAP Market Expands with Wearables and Digital Tools.

ResMed's 15min chart: Bollinger Bands Narrowing, KDJ Death Cross detected.

ResMed's 15min chart sees MACD Death Cross, Bollinger Bands Narrowing.

Catalyst<ul> <li>Positive net inflow trends across all fund sizes indicate growing institutional interest in RMD.</li></ul>Risk<ul> <li>Technical signals show a volatile and uncertain market direction with mixed short-long signals.</li> <li>Analyst ratings for RMD are inconsistent, with three Neutral ratings highlighting valuation concerns.</li></ul>

Key Factors

ResMed Inc. [RMD] reports that Director Farrell Peter C sold 2000 shares at $251.31 per share on February 4, 2026.ResMed’s Q2 profit increased 11% in 2026 as demand rose due to Ozempic-linked sleep apnea screening and expanded use of wearable and digital health tools.

RMD News